Two years recurrence rate of ovarian and endometrial malignancies following Surgical versus clinical staging


  • Shokhan Faeq Rashid
  • Maryam Bakir Mahmood
  • Taher Abdullah Hussein Hawramy



Gynecological cancer, Recurrence, Standard surgical staging


Background and objectives: Gynecological cancers represent a big burden on national health institutes. Recurrences of these cancers are documented frequently that needed more efforts to prevent or reduce them.  The aim of the study was to know the difference between Standard Surgical Staging and Non-Standard Surgical Staging in gynecological cancers in terms of recurrence rate.

Methods: This study was a retrospective cross-sectional study conducted at the Maternity Teaching Hospital and Hiwa Hospital in Sulaymaniyah city-Kurdistan region/Iraq over two years from June 2020 to June 2022, on sample of 86 women with gynecological cancer divided into two study groups (42 women underwent standard surgical staging and 44 women underwent non-standard surgical staging). Standard surgical staging for endometrial and ovarian cancers included midline laparotomy, peritoneal washout, samples from the right and left sub-diaphragmatic surfaces, infracoloic Omentectomy, total abdominal hysterectomy & bilateral salpingo-oophorectomy, any peritoneal deposits and pelvic and para-aortic Lymphadenectomy in maternity hospital.

Results: The recurrence rate in women with non-standard surgical staging were 25% (p=0.009), while in women with standard surgical staging were 4.8%. 11 women with non-standard surgical staging had advanced cancer stages at recurrence compared to 2 cases with standard surgical staging. Although no significant difference in death outcome between both study groups (p=0.09), no woman who underwent standard surgical staging with recurrence died, while the death rate of women underwent non-standard surgical staging with recurrence was (63.6%).

 Conclusions: The standard surgical staging in women with gynecological cancer is important in the   recurrence rate of these cancers.


Download data is not yet available.


Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424.

Sekhon R, Bhatla N. Gynecological cancer update. Asian J Oncol 2016; 2(02):061-2.

Haward RA. The Calman-Hine report: a personal retrospective on the UK’s first comprehensive policy on cancer services. Lancet Oncol 2006; 7(4):336–46.

Scott R, Hawarden A, Russell B, Edmondson RJ. Decision-Making in Gynaecological Oncology Multidisciplinary Team Meetings: A Cross-Sectional, Observational Study of Ovarian Cancer Cases. Oncol Res Treat 2020; 43:70-7.

Taberna M, Gil Moncayo F, Jané-Salas Eet al. The Multidisciplinary Team (MDT) Approach and Quality of Care. Front Oncol 2020; 10:85.

Rungruang B, Olawaiye AB. Comprehensive surgical staging for endometrial cancer. Rev ObstetGynecol 2012; 5(1):28-34.

Milam, Michael R.MD, MPH; Java et al. Gynecologic Oncology Group. Nodal metastasis risk in endometrial cancer 2012.Obstet Gyneco2012; 119 (2):286-92.

Creasman WT, Odicino F, Maisonneuve P. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2011; 95(1):105–43.

Todo Y, Yamamoto R, Minobe S. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. GynecolOncol 2010; 119:60–4.

Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C. ESMO Guidelines Working Group. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24(6):24–32.

Benedet JL, Bender H, Jones 3rd H, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology. Int J GynaecolObstet 2010; 70:209–62.

Backes FJ, Martin DD. Intraoperative radiation therapy (IORT) for gynecologic malignancies. Gynecol Oncol 2015; 138:449–56.

Bradford LS, Rauh-Hain JA, Schorge J, Birrer MJ, Dizon DS. Advances in the management of recurrent endometrial cancer. Am J Clin Oncol 2015; 38:206–12.

Garzon S, Laganà AS, Casarin J et al. Secondary and tertiary ovarian cancer recurrence: what is the best management? Gland Surg 2020; 9(4):1118-29.

Nikolopoulos M, Godfrey M, Sohrabi F, Wong M, Bhatte D, Wuntakal R. Stage one endometrioid endometrial adenocarcinoma: is there a role of traditional hospital follow-up in the detection of cancer recurrence in women after treatment? ObstetGynecol Sci 2021; 64(6):506-16.

Nwachukwu C, Baskovic M, Von Eyben R et al. Recurrence risk factors in stage IA grade 1 endometrial cancer. J Gynecol Oncol 2021; 32(2):e22.

Okunade KS, Adetuyi IE, Adenekan M, Ohazurike E, Anorlu RI. Risk predictors of early recurrence in women with epithelial ovarian cancer in Lagos, Nigeria. Pan Afr Med J 2020; 36:272.

Timmers PJ, Zwinderman AH, Coens C, Vergote I, Trimbos JB. Understanding the problem of inadequately staging early ovarian cancer. Eur J Cancer 2010; 46:880–4.

Hengeveld EM, Zusterzeel PLM, Lajer H, Høgdall CK, Rosendahl M. The value of surgical staging in patients with apparent early stage epithelial ovarian carcinoma. GynecolOncol 2019; 154:308–13.

Laven P, Beltman JJ, Bense JEet al. Incomplete surgical staging in clinical early-stage ovarian cancer: guidelines versus daily practice. Surg Open Sci 2021; 7:6-11.

Mjali A, Jawad SA, Al Baroodi BNH. Gynecological Cancer in Middle Euphrates Region of Iraq, 2012-2020. Asian Pacific Journal of Environment and Cancer 2020; 3 (1): 17-8.

KhoshnawN, Mohammed HA, Abdullah DA. Patterns of Cancer in Kurdistan -Results of Eight Years Cancer Registration in Sulaymaniyah Province-Kurdistan-Iraq. Asian Pac J Cancer Prev 2015; 16(18):8525-31.

Ibrahim H, Abbas A. Risk Factors and Symptoms of Ovarian Cancer in Patients Attending Hiwa Oncology/Hematology Hospital in Sulaimaniyah City. Kufa Journal for Nursing Sciences 2021; 11(2).

Iyoke CA, Ugwu GO, Ezugwu EC, Ezugwu FO, Lawani OL, Onyebuchi AK. Challenges associated with the management of gynecological cancers in a tertiary hospital in South East Nigeria. Int J Womens Health 2014; 6:123-30.

Swift BE, Covens A, Mintsopoulos V. The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma. Int J Gynecol Cancer 2022; 32:525-31.

Neubauer NL, Lurain JR. The role of lymphadenectomy in surgical staging of endometrial cancer. Int J Surg Oncol 2011;81: 46-9.

Trimbos B, Timmers P, Pecorelli Set al. Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial. J Natl Cancer Inst 2010; 102(13):982-7.

Romeo M, Pons F, Barretina P, Radua J. Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor. World J Surg Oncol 2013; 11:13.

Falzone L, Scandurra G, Lombardo Vet al. A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review). Int J Oncol 2021; 59(1):53.

Singh S, Raidoo S, Pettigrew G, Debernardo R. Management of early stage, high-risk endometrial carcinoma: preoperative and surgical considerations. ObstetGynecol Int 2013; 757249.

Concin N, Matias-Guiu X, Vergote I. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 2021; 31:12-39.

Lheureux S, Gourley C, Vergote I. Epithelial ovarian cancer. Lancet 2019; 393:1240–53.

Wang Q, Zheng Y, Wang Pet al. The prognostic factor for recurrence in advanced-stage high-grade serous ovarian cancer after complete clinical remission: a nested case-control study. J Ovarian Res 2021; 14(1):179.

Zahnd WE, Hyon KS, Diaz-Sylvester P, Izadi SR, Colditz GA, Brard L. Rural-urban differences in surgical treatment, regional lymph node examination, and survival in endometrial cancer patients. Cancer Causes Control 2018; 29(2):221-32.

Kanno M, Yunokawa M, Nakabayashi M et al. Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer. Sci Rep 2022; 12(1):166.

Foerste R, Kluck R, Arians N. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist’s point of view. Radiat Oncol 2015; 10: 147.




How to Cite

Rashid, S. F. ., Mahmood, M. B. ., & Hawramy, T. A. H. . (2024). Two years recurrence rate of ovarian and endometrial malignancies following Surgical versus clinical staging. AMJ (Advanced Medical Journal) , 9(1), 77-88.